OcellO joins Crown Bioscience! Learn more…


1408, 2019

OcellO at AACR-NCI-EORTC Boston: Visit our booth #1628

August 14th, 2019|

OcellO team will be joining AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston on the 26-30th October. We look forward to meeting with you ! If you like to set up a one-to-one meeting, you can reach us at [email protected] otherwise come by our booth #1628. Please follow the link for more information about this conference;

2603, 2019

Press Release

March 26th, 2019|

OcellO announces two year agreement with Merus to provide in vitro research services for MCLA-158 and other undisclosed Biclonics ® programs LEIDEN, the Netherlands, March. 28, 2019 OcellO B.V., a Contract Research Organisation offering 3D cell based assay services for drug discovery to the pharmaceutical industry, today announced that it entered an agreement to provide in vitro research services to Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, for Merus’ MCLA-158 Biclonics® program and [...]

Heads up for Michiel Fokkelman, OcellO's Head of High Throughput Screening, who stands behind advancing OcellO's automation technology. @crownbioscience

Meet OcellO's Head of IT Ashgard Weterings whose team helps OcellO to deliver to the customers rich data on their compounds with a special focus on speed and quality.

We are inviting you to the 2021 Virtual 3D Cell Culture Summit, where Mariusz Madej, Senior Scientist Oncology and Head of Biobanking, will present OcellO's unique screening platform. #CrownBio

Register today and join us on June 16th, 12:15-12:45pm CEST:

Mariusz Madej, OcellO's Senior Scientist Oncology and Head of Biobanking, has been the driving force behind growing OcellO's organoid collection. Mariusz leads the effort in new models' establishment and expansion of existing collections as well as multiple commercial projects.

Heads up for Cinthya Del Angel Zuvirie, OcellO's Associate Scientist, bringing great enthusiasm and passion to set up new and expanding existing organoid models for 3D high-throughput-screening assays.

Meet Hester Bange, OcellO's Senior Scientist, Head of Cystopathic Diseases, who shows that OcellO keeps physiological relevance of models and data-rich read-outs hand to hand, and at the same time creates a motivating environment for scientists to work and grow.

Load More...
Go to Top